DOJ Obtains $1.4B in Largest Opioid Drug Case Recovery in U.S. History

July 11, 2019 Global consumer goods conglomerate Reckitt Benckiser Group plc (RB Group) has agreed to pay $1.4 billion to resolve its potential criminal and civil liability related to a federal investigation of the marketing of the opioid addiction treatment drug Suboxone. The resolution – the largest recovery by the United States in a case…

 Continue reading

OIG: Impact of Prescribed Opioids on Postal Employees Under the Federal Workers’ Comp Program

Objective Our objective was to determine the impact of opioids being prescribed to U.S. Postal Service employees through the U.S. Department of Labor’s (DOL) Federal Employees’ Compensation Act (FECA) program. According to the National Institute on Drug Abuse, pharmaceutical companies in the 1990s assured the medical community that opioid pain relievers were not addictive. As…

 Continue reading

USPS OIG Report: Opioid Safety Preparedness

Objective This report responds to a request from the U.S. House Committee on Oversight and Government Reform to review measures the U.S. Postal Service has implemented regarding opioid safety preparedness. Specifically, the congressional inquiry focused on Postal Service procedures, training, and communications related to employee exposure risks to synthetic opioids and opioid overdose medication. Our…

 Continue reading

Postal loophole allows opioids from abroad to flood into Florida

Op-Ed By Juliette Kayyem – December 20, 2017 Just a few weeks ago a Davie, Florida, couple, Anthony Gomes and Elizabeth Ton, were arrested for widely distributing deadly drugs they purchased over the internet from China. While their crimes afforded them lavish luxuries, including a private plane, the illicit drug trade came at an enormous…

 Continue reading